Literature DB >> 18720477

A critique of the false-positive report probability.

Joseph F Lucke1.   

Abstract

The false positive report probability (FPRP) was proposed as a Bayesian prophylactic against false reports of significant associations. Unfortunately, the derivation of the FPRP is unsound. A heuristic derivation fails to make its point, and a formal derivation reveals a probabilistic misrepresentation of an observation. As a result, the FPRP can yield serious inferential errors. In particular, the FPRP can use an observation that is many times more likely under the null hypothesis than under the alternative to infer that the null hypothesis is far less probable than the alternative. Contrary to its intended purpose, the FPRP can promote false positive results. It should not be used. A modified FPRP is derived, but it appears to have limited application and does not address the problem of false reports of significant associations. The conditional error probability is a possible replacement for the FPRP.

Mesh:

Year:  2009        PMID: 18720477     DOI: 10.1002/gepi.20363

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  15 in total

1.  A simple Bayesian mixture model with a hybrid procedure for genome-wide association studies.

Authors:  Yu-Chung Wei; Shu-Hui Wen; Pei-Chun Chen; Chih-Hao Wang; Chuhsing K Hsiao
Journal:  Eur J Hum Genet       Date:  2010-04-21       Impact factor: 4.246

2.  Distinguishing true from false positives in genomic studies: p values.

Authors:  Linda Broer; Christina M Lill; Maaike Schuur; Najaf Amin; Johannes T Roehr; Lars Bertram; John P A Ioannidis; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2013-02-01       Impact factor: 8.082

3.  Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck.

Authors:  Hongping Yu; Li-E Wang; Zhensheng Liu; Sheng Wei; Guojun Li; Erich M Sturgis; Qingyi Wei
Journal:  Pharmacogenet Genomics       Date:  2011-07       Impact factor: 2.089

4.  Field Synopsis and Re-analysis of Systematic Meta-analyses of Genetic Association Studies in Multiple Sclerosis: a Bayesian Approach.

Authors:  Jae Hyon Park; Joo Hi Kim; Kye Eun Jo; Se Whan Na; Michael Eisenhut; Andreas Kronbichler; Keum Hwa Lee; Jae Il Shin
Journal:  Mol Neurobiol       Date:  2017-10-12       Impact factor: 5.590

5.  Global tests of P-values for multifactor dimensionality reduction models in selection of optimal number of target genes.

Authors:  Hongying Dai; Madhusudan Bhandary; Mara Becker; J Steven Leeder; Roger Gaedigk; Alison A Motsinger-Reif
Journal:  BioData Min       Date:  2012-05-22       Impact factor: 2.522

6.  Quantifying posterior effect size distribution of susceptibility loci by common summary statistics.

Authors:  Olga A Vsevolozhskaya; Dmitri V Zaykin
Journal:  Genet Epidemiol       Date:  2020-02-25       Impact factor: 2.344

7.  Assessing the Probability that a Finding Is Genuine for Large-Scale Genetic Association Studies.

Authors:  Chia-Ling Kuo; Olga A Vsevolozhskaya; Dmitri V Zaykin
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

8.  The ranking probability approach and its usage in design and analysis of large-scale studies.

Authors:  Chia-Ling Kuo; Dmitri Zaykin
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

9.  SNP prioritization using a Bayesian probability of association.

Authors:  John R Thompson; Martin Gögele; Christian X Weichenberger; Mirko Modenese; John Attia; Jennifer H Barrett; Michael Boehnke; Alessandro De Grandi; Francisco S Domingues; Andrew A Hicks; Fabio Marroni; Cristian Pattaro; Fabrizio Ruggeri; Giuseppe Borsani; Giorgio Casari; Giovanni Parmigiani; Andrea Pastore; Arne Pfeufer; Christine Schwienbacher; Daniel Taliun; Caroline S Fox; Peter P Pramstaller; Cosetta Minelli
Journal:  Genet Epidemiol       Date:  2012-12-26       Impact factor: 2.135

10.  Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial.

Authors:  Orestis A Panagiotou; Brian L Befano; Paula Gonzalez; Ana Cecilia Rodríguez; Rolando Herrero; John T Schiller; Aimée R Kreimer; Mark Schiffman; Allan Hildesheim; Allen J Wilcox; Sholom Wacholder
Journal:  BMJ       Date:  2015-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.